We have located links that may give you full text access.
Serum HMGB1 levels and its association with endothelial dysfunction in patients with polycystic ovary syndrome.
Physiological Research 2018 September 12
High-mobility group box1(HMGB1) is newly discovered protein, which play a crucial role in the pathogenesis of systemic inflammation Recent studies showed that HMGB1 is one of the important pathophysiological mechanisms in the occurrence and development of atherosclerosis. The purpose of the present study was to investigate the relationship between serum HMGB1 levels and endothelial function in patients with polycystic ovary syndrome (PCOS). 80 newly diagnosed patients with PCOS and 80 normal women of similar age were selected. Metformin treatment (1500 mg/d) was initiated in all patients for a period of consecutive 3 months. Serum HMGB1 levels were measured by ELISA. High resolution ultrasound was used to measure the brachial artery diameter at rest, after reactive hyperemia (flow-mediated arterial dilation, FMD) and after sublingual glyceryltrinitrate. Serum HMGB1 levels in PCOS were 24.87+/-14.93 ng/ml, which were significantly higher than that in controls (8.82+/-3.55 ng/ml) (p<0.01). After 3 months treatment, serum HMGB1 levels decreased significantly (p < 0.05).By dividing the distribution of HMGB1 levels into quartiles, serum HMGB1 levels were increased gradually with the increase of testosterone levels (p < 0.05),whereas the FMD levels decreased (p < 0.05). Multiple stepwise linear regression analysis showed that FMD (estimated coefficient (beta)=-0.69, p=0.005), testosterone (beta=0.31, p =0.045), TBARS (beta=0.69, p=0.012) and hs-CRP levels (beta=0.68, p=0.001) were significantly associated with HMGB1.The absolute changes in HMGB1 showed a positive correlation with the changes in testosterone (p < 0.05) and negative correlation with the changes in FMD (p < 0.05) in patients with PCOS during the course of metformin therapy. Serum HMGB1 levels are correlated with endothelil dysfunction in patients with PCOS Our study suggests that HMGB1 may contribute to the early stage of atherosclerosis in patients with PCOS.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app